SCHEDULE I-ADDITIONAL FINANCIAL INFORMATION OF PARENT COMPANY (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
|---|
| SCHEDULE I-ADDITIONAL FINANCIAL INFORMATION OF PARENT COMPANY |
|
| CONDENSED BALANCE SHEETS |
| | | | | | | As of December 31, | | | 2024 | | 2025 | | | US$ | | US$ | ASSETS | | | | | Current assets: | | | | | Cash and cash equivalents | | 245,740 | | 1,006 | Prepaid expenses and other current assets | | 1,670 | | — | Total current assets | | 247,410 | | 1,006 | Advances to subsidiaries and VIEs | | 21,908 | | 121,376 | TOTAL ASSETS | | 269,318 | | 122,382 | LIABILITIES AND SHAREHOLDERS’ DEFICIT | | | | | Current liabilities: | | | | | Accrued expenses and other current liabilities | | 136,353 | | 100,571 | Accrued salary and benefits | | 250,000 | | 170,000 | Other current liabilities | | — | | — | Total current liabilities | | 386,353 | | 270,571 | Advances from subsidiaries and VIEs | | — | | — | Other non-current liabilities | | — | | — | TOTAL LIABILITIES | | 386,353 | | 270,571 | SHAREHOLDERS’ DEFICIT: | | | | | Ordinary shares | | 48,372 | | 48,372 | Additional paid-in capital | | 218,379,858 | | 218,417,583 | Accumulated deficit | | (216,859,796) | | (216,937,975) | Accumulated other comprehensive loss | | (1,685,469) | | (1,676,169) | Total shareholders’ deficit | | (117,035) | | (148,189) | TOTAL LIABILITIES AND SHAREHOLDERS’ (DEFICIT)/ EQUITY | | 269,318 | | 122,382 |
|
| CONDENSED STATEMENTS OF OPERATIONS |
| | | | | | | | | For the years ended December 31, | | | 2023 | | 2024 | | 2025 | | | US$ | | US$ | | US$ | Net revenues | | — | | — | | — | Cost of revenues | | — | | — | | — | Gross loss | | — | | — | | — | Operating expenses: | | | | | | | General and administrative expenses | | (1,468,711) | | (438,071) | | (374,879) | Research and development expenses | | (39,909) | | (60,297) | | (24,033) | Sales and marketing expenses | | — | | — | | — | Other operating income, net | | 136,129 | | 136,129 | | 40,585 | Total operating expenses | | (1,372,491) | | (362,239) | | (358,327) | Loss from operations | | (1,372,491) | | (362,239) | | (358,327) | Interest expenses, net | | (7,490) | | 1,652 | | 4,740 | Fair value change of derivatives | | — | | — | | — | Foreign exchange gains (losses), net | | (1) | | (3) | | — | Loss before income taxes and equity in earnings of subsidiaries | | (1,379,982) | | (360,590) | | (353,587) | Net loss before equity in earnings of subsidiaries | | (1,379,982) | | (360,590) | | (353,587) | Equity in (loss) income of subsidiaries and share of (loss) income from VIEs | | (1,215,959) | | 424,159 | | 275,408 | Net (loss) income attributed to CooTek (Cayman) Inc. | | (2,595,941) | | 63,569 | | (78,179) |
|
| CONDENSED STATEMENTS OF CASH FLOWS |
| | | | | | | | | For the years ended December 31, | | | 2023 | | 2024 | | 2025 | | | US$ | | US$ | | US$ | Operating activities: | | | | | | | Net (loss) income | | (2,595,941) | | 63,569 | | (78,179) | Equity in (income) loss of subsidiaries, VIEs and VIEs’ subsidiaries | | 1,215,959 | | (424,159) | | (275,408) | Adjustment to reconcile net loss to net cash provided by (used in) operating activities: | | | | | | | Share-based compensation | | 704,565 | | 134,560 | | 37,725 | Amortization of issuance cost and debt discounts related to convertible notes | | 51,797 | | — | | — | Change in fair value of derivatives | | — | | — | | — | Changes in assets and liabilities: | | | | | | | Accrued expenses and other current liabilities | | 292,842 | | (741,434) | | (35,784) | Other receivables, deposits and other assets | | — | | 1,692 | | 1,670 | Accrued salary and benefits | | (138,975) | | (33,000) | | (80,000) | Other non-current liabilities | | (136,129) | | (35,783) | | — | Net cash used in operating activities | | (605,882) | | (1,034,555) | | (429,976) | Investing activities: | | | | | | | Advances to subsidiaries and VIEs | | (4,819,580) | | (974,894) | | (2,136,760) | Repayment of advances to subsidiary | | 6,607,179 | | 2,250,000 | | 2,322,002 | Net cash provided by investing activities | | 1,787,599 | | 1,275,106 | | 185,242 | Financing activities: | | | | | | | Proceeds from issuance of ordinary shares upon exercise of options | | — | | — | | — | Repayment of convertible notes | | (1,806,453) | | — | | — | Net cash (used in) provided by financing activities | | (1,806,453) | | — | | — | Net (decrease) increase in cash, cash equivalents and restricted cash | | (624,736) | | 240,551 | | (244,734) | Cash, cash equivalents and restricted cash at beginning of year | | 629,925 | | 5,189 | | 245,740 | Cash, cash equivalents and restricted cash at end of year | | 5,189 | | 245,740 | | 1,006 |
|